Your browser doesn't support javascript.
loading
Bioinformatics-based analysis reveals elevated CYTL1 as a potential therapeutic target for BRAF-mutated melanoma.
Tao, Lei; Cui, Yingyue; Sun, Jiarui; Cao, Yu; Dai, Zhen; Ge, Xiaoming; Zhang, Ling; Ma, Run; Liu, Yunyao.
Affiliation
  • Tao L; Nanjing Institute for Food and Drug Control, Nanjing, China.
  • Cui Y; State Key Laboratory of Natural Medicines, School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China.
  • Sun J; State Key Laboratory of Natural Medicines, School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China.
  • Cao Y; Nanjing Institute for Food and Drug Control, Nanjing, China.
  • Dai Z; Nanjing Institute for Food and Drug Control, Nanjing, China.
  • Ge X; Nanjing Institute for Food and Drug Control, Nanjing, China.
  • Zhang L; Nanjing Institute for Food and Drug Control, Nanjing, China.
  • Ma R; The Second Affiliated Hospital of Kunming Medical University, Kunming, China.
  • Liu Y; State Key Laboratory of Natural Medicines, School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China.
Front Cell Dev Biol ; 11: 1171047, 2023.
Article in En | MEDLINE | ID: mdl-37745303
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Front Cell Dev Biol Year: 2023 Document type: Article Affiliation country:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Front Cell Dev Biol Year: 2023 Document type: Article Affiliation country: